Recently, attention has been focused on the relationship between reactive oxygen species (ROS) and several disorders including aging, various inflammatory diseases, carcinogenesis, neurodegenerative diseases, and diabetes. 1) In fact, diabetes is usually accompanied by increased production of ROS 2) and impaired antioxidant defense, 3) indicating a central contribution of ROS to the onset, progression, and pathological consequences of diabetes. There is considerable evidence that chronic hyperglycemia is the proximate cause of retinopathy, kidney failure, neuropathies, and macrovascular diseases in diabetes.1) In addition, it has been demonstrated that b cells are particularly susceptible to oxidative damage.
4)Therefore, as hyperglycemia worsens, b cells steadily deteriorate, secrete less insulin, and participate in a downward spiral of loss of pancreatic functions.The current treatments of diabetes are based on a combination of diet, oral hypoglycemic agents, and insulin intake, which focus on decreasing the blood glucose level.5) Although some oral hypoglycemic agents have been associated with enhancement of the antioxidant system, 6) they do not prevent the gradual loss of b-cell functions, which is known to account for gradual deterioration of glucose homeostasis. Therefore, the treatment of micro-and macrovascular complications has required the combined use with several herbal preparations and dietary supplements.7) Many natural products 8,9) and medicinal plants 7) have been shown to significantly reduce oxidative stress and increase the antioxidant endogenous system, which represent a important property of plant medicines used for the treatment of several diseases including diabetes. In this sense, approximately 306 species from 235 genera and 93 families have been used empirically as hypoglycemic agents in Mexican traditional medicine.
10)Eysenhardtia platycarpa, E. subcoriacea, and E. punctata, known indiscriminately as 'palo dulce' (sweet wood), are traditionally used for the treatment of bladder infections and kidney diseases related to diabetes. 11) Eysenhardtia is a small genus that comprises 14 species indigenous to North and Central Mexico.12) Previous studies on Eysenhardtia species have highlighted the hypoglycemic activity of E. polystachya 13) and the antihyperglycemic activity of E. platycarpa, 14) as well as the isolation of cytotoxic flavonoids 15,16) and 3-O-acetyloleanolic acid [which displayed antihyperglycemic activity in streptozotocin (STZ)-induced diabetic rats 14) ]. As part of our screening of plants for the isolation of substances with antioxidant and antihyperglycemic potential, 14,17) this study was conducted to A) assess the antioxidant effects of extracts from E. platycarpa, E. punctata, and E. subcoriacea, as well as of compounds 1-8, natural constituents isolated from E. platycarpa (Chart 1), in a rat pancreas model and in a 1,1 diphenyl-2-picrylhydrazyl (DPPH) radical scavenger assay; B) synthesize 1, which displayed a protective effect against 2,2-azo-bis(2-amidinopropane...